[Antitumor activity of recombinant human tumor necrosis factor (TNF)].
D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy; D002460:Cell Line; D002478:Cells, Cultured; D006023:Glycoproteins / Q000627:therapeutic use*; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000473:pathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha
D006023:Glycoproteins; D006131:Growth Inhibitors; D014409:Tumor Necrosis Factor-alpha